- In May 2024, Intuitive received FDA clearance for its fifth-generation robotic system, the da Vinci 5, marking a significant advancement in robotic-assisted surgery technology
- In January 2024, Boston Scientific Corporation entered into an agreement to acquire Axonics, Inc., enabling the company to expand into sacral neuromodulation and enhance patient access to care in this growing field
- In November 2023, Medtronic received approval from the U.S. Food and Drug Administration (FDA) for its Symplicity Spyral renal denervation (RDN) system, also known as the Simplicity blood pressure procedure, designed to treat hypertension
- In November 2023, Johnson & Johnson MedTech announced that its MONARCH Platform and MONARCH Bronchoscope received regulatory approval in China
- In December 2023, EndoQuest Robotics, Inc. successfully closed a USD 42 million C-1 preferred financing round, allowing further development of their flexible endoluminal robot to revolutionize minimally invasive surgeries
